A Review on Biosensors for Quantification of MCP‐1 as a Potential Biomarker in Diseases DOI

Zahra Jamalizadeh Bahaabadi,

Mohammad Javad Javid‐Naderi,

Prashant Kesharwani

et al.

Immunology, Journal Year: 2025, Volume and Issue: unknown

Published: May 14, 2025

ABSTRACT Monocyte chemoattractant protein‐1 (MCP‐1) as a chemokine is essential for inflammation‐related processes. It regulates immunological responses and cell migration, which contribute to inflammation. Many disorders are exacerbated by this chemokine, attracts or grows other inflammatory cells, including monocytes/macrophages, at the site of infection tissue injury. The elevated concentrations MCP‐1 associated with pathogenesis many diseases, such cancer, cardiovascular disease, kidney neuroinflammatory disease. Therefore, monitoring biomarker in body has been recommended strongly advised make an accurate diagnosis prognosis. Although great importance disease processes, few biosensing approaches specifically designed detect molecule. These often electrochemical optical techniques. Rapid diseases identifying biomarkers had effect on advancement biosensors. Improved biosensor technology expansion prevents excessive prices low sensitivity, enabling quick correct tracking This review will concentrate biological functions MCP‐1, its significance different disorders, features applications biosensors detection quantification.

Language: Английский

A Review on Biosensors for Quantification of MCP‐1 as a Potential Biomarker in Diseases DOI

Zahra Jamalizadeh Bahaabadi,

Mohammad Javad Javid‐Naderi,

Prashant Kesharwani

et al.

Immunology, Journal Year: 2025, Volume and Issue: unknown

Published: May 14, 2025

ABSTRACT Monocyte chemoattractant protein‐1 (MCP‐1) as a chemokine is essential for inflammation‐related processes. It regulates immunological responses and cell migration, which contribute to inflammation. Many disorders are exacerbated by this chemokine, attracts or grows other inflammatory cells, including monocytes/macrophages, at the site of infection tissue injury. The elevated concentrations MCP‐1 associated with pathogenesis many diseases, such cancer, cardiovascular disease, kidney neuroinflammatory disease. Therefore, monitoring biomarker in body has been recommended strongly advised make an accurate diagnosis prognosis. Although great importance disease processes, few biosensing approaches specifically designed detect molecule. These often electrochemical optical techniques. Rapid diseases identifying biomarkers had effect on advancement biosensors. Improved biosensor technology expansion prevents excessive prices low sensitivity, enabling quick correct tracking This review will concentrate biological functions MCP‐1, its significance different disorders, features applications biosensors detection quantification.

Language: Английский

Citations

0